Gyu Hwan Park Selected Research

18-dehydroxyl-17-demethoxyreblastatin

10/2014

Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gyu Hwan Park Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 06/2009
3	Glioma (Gliomas) 07/2022 - 05/2011
3	Cognitive Dysfunction 01/2018 - 09/2014
3	Neoplasms (Cancer) 02/2016 - 01/2013
3	Amyloid Plaque 01/2013 - 06/2009
2	Amnesia (Dissociative Amnesia) 01/2018 - 09/2014
2	Edema (Dropsy) 04/2013 - 01/2013
2	Inflammation (Inflammations) 01/2013 - 08/2005
2	Neuroinflammatory Diseases 09/2009 - 07/2008
1	Alveolar Bone Loss 01/2019
1	Periodontitis 01/2019
1	Brain Diseases (Brain Disorder) 01/2017
1	Dementia (Dementias) 01/2017
1	Memory Disorders (Memory Loss) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 02/2016
1	Infections 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Epstein-Barr Virus Infections 02/2015
1	Carcinoma (Carcinomatosis) 02/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2014
1	Lung Neoplasms (Lung Cancer) 10/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Erythema 01/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2005

Drug/Important Bio-Agent (IBA)

3	Amyloid (Amyloid Fibrils)IBA 11/2017 - 06/2011
3	Biological ProductsIBA 01/2017 - 01/2013
2	Carbon MonoxideIBA 07/2022 - 01/2018
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2018 - 05/2011
2	Scopolamine (Hyoscine)FDA Link 01/2018 - 09/2014
2	gingerolIBA 01/2018 - 01/2013
2	Peptides (Polypeptides)IBA 11/2017 - 01/2013
2	Heme Oxygenase-1IBA 01/2017 - 05/2011
2	EnzymesIBA 01/2017 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2013
2	AntioxidantsIBA 01/2017 - 05/2011
2	Cyclin D1IBA 02/2016 - 01/2013
2	Small Interfering RNA (siRNA)IBA 02/2016 - 01/2013
2	genipinIBA 01/2016 - 02/2015
2	Antiviral Agents (Antivirals)IBA 01/2016 - 02/2015
2	ErbB Receptors (EGF Receptor)IBA 10/2014 - 01/2013
2	Thrombin FDA Link 09/2009 - 07/2008
2	Peroxynitrous Acid (Peroxynitrite)IBA 08/2005 - 07/2005
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019
1	CytokinesIBA 01/2019
1	Neuroprotective AgentsIBA 01/2018
1	tau Proteins (tau Protein)IBA 11/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2017
1	LipidsIBA 01/2017
1	Superoxide DismutaseIBA 01/2017
1	NF-E2-Related Factor 2IBA 01/2017
1	AdiponectinIBA 02/2016
1	Caspase 3 (Caspase-3)IBA 02/2016
1	Tyrosine Kinase InhibitorsIBA 10/2014
1	18-dehydroxyl-17-demethoxyreblastatinIBA 10/2014
1	Gefitinib (Iressa)FDA Link 10/2014
1	geldanamycinIBA 10/2014
1	Dietary Fiber FDA Link 09/2014
1	arabinoxylanIBA 09/2014
1	Pharmaceutical PreparationsIBA 12/2013
1	Glutamic Acid (Glutamate)FDA Link 12/2013
1	liquiritigeninIBA 12/2013
1	Anti-Allergic Agents (Antiallergic Agents)IBA 04/2013
1	Retinoblastoma ProteinIBA 01/2013
1	Cysteine (L-Cysteine)FDA Link 01/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2013
1	zinc protoporphyrinIBA 05/2011
1	stannous chloride (tin chloride)FDA LinkGeneric 05/2011
1	Proteinase-Activated ReceptorsIBA 09/2009
1	Peptide Hydrolases (Proteases)FDA Link 09/2009
1	TrypsinIBA 09/2009
1	peptide AIBA 06/2009
1	Amyloid beta-PeptidesIBA 06/2009
1	Superoxides (Superoxide)IBA 08/2005
1	purineIBA 07/2005
1	Adenosine (Adenocard)FDA LinkGeneric 07/2005

Therapy/Procedure

1	Photochemotherapy (Photodynamic Therapy) 01/2019
1	Oral Administration 09/2014